Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

<div>Forrest plot for overall survival after unresectable treatment in patients of HBV-related HCC: (a) patients treated with lamivudine; (b) patients treated with various nucleot(s)ide analogs.</div>

Disease Markers

fig4

Figure 4

Figure 4: Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 

Figure 4 | Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 